Table of Contents
ISRN Urology
Volume 2011, Article ID 261735, 4 pages
http://dx.doi.org/10.5402/2011/261735
Case Report

Giant Retroperitoneal Mucinous Tumor Supportively Diagnosed as a Dedifferentiated Liposarcoma by Fluorescence In Situ Hybridization of MDM2 Gene

1Department of Nephro-urology, Graduate School of Medical Sciences, Nagoya City University, Mizuho-ku 467-8601, Nagoya, Japan
2Department of Experimental Pathology and Tumor Biology, Graduate School of Medical Sciences, Nagoya City University, Mizuho-ku 467-8601, Nagoya, Japan

Received 10 March 2011; Accepted 27 April 2011

Academic Editors: P.-L. Chang, A. M. El-Assmy, and V. Serretta

Copyright © 2011 Taku Naiki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. M. Mack, “Sarcomas and other malignancies of soft tissue, retroperitoneum, peritoneum, pleura, heart, mediastinum, and spleen,” Cancer, vol. 75, supplement 1, pp. 211–244, 1995. View at Google Scholar
  2. E. A. Perez, J. C. Gutierrez, F. L. Moffat Jr. et al., “Retroperitoneal and truncal sarcomas: prognosis depends upon type not location,” Annals of Surgical Oncology, vol. 14, no. 3, pp. 1114–1122, 2007. View at Google Scholar · View at Scopus
  3. S. Singer, C. R. Antonescu, E. Riedel, and M. F. Brennan, “Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma,” Annals of Surgery, vol. 238, no. 3, pp. 358–371, 2003. View at Google Scholar · View at Scopus
  4. A. G. Nascimento, “Dedifferentiated liposarcoma,” Seminars in Diagnostic Pathology, vol. 18, no. 4, pp. 263–266, 2001. View at Google Scholar · View at Scopus
  5. J. M. Coindre, O. Mariani, F. Chibon et al., “Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma,” Modern Pathology, vol. 16, no. 3, pp. 256–262, 2003. View at Publisher · View at Google Scholar · View at PubMed
  6. E. Fabre-Guillevin, J. M. Coindre, S. Somerhausen Nde, F. Bonichon, E. Stoeckle, and N. B. Bui, “Retroperitoneal liposarcomas: follow-up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas,” Cancer, vol. 106, no. 12, pp. 2725–2733, 2006. View at Publisher · View at Google Scholar · View at PubMed
  7. J. Weaver, E. Downs-Kelly, J. R. Goldblum et al., “Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms,” Modern Pathology, vol. 21, no. 8, pp. 943–949, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. H. Zhang, M. Erickson-Johnson, X. Wang et al., “Molecular testing for lipomatous tumors: critical analysis and test recommendations based on the analysis of 405 extremity-based tumors,” American Journal of Surgical Pathology, vol. 34, no. 9, pp. 1304–1311, 2010. View at Publisher · View at Google Scholar · View at PubMed
  9. G. A. Porter, N. N. Baxter, and P. W. Pisters, “Retroperitoneal sarcoma: a population-based analysis of epidemiology, surgery, and radiotherapy,” Cancer, vol. 106, no. 7, pp. 1610–1616, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. K. Inoue, Y. Higaki, and H. Yoshida, “Giant retroperitoneal liposarcoma,” International Journal of Urology, vol. 12, no. 2, pp. 220–222, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus